Skip to main content
Glama

Health ChEMBL Bioactive Molecules

health_chEMBL_bioactive_molecules
Read-only

EMBL-EBI ChEMBL molecule search: ChEMBL ID, preferred name, maximum clinical phase, molecule type, molecular weight, canonical SMILES, first approval year and ATC codes. Up to 20 molecules per call, with total match count. Price: $0.002 in USDC per successful call, paid with x402 (Base, Solana or Arc); failed calls are not charged.

Input Schema

NameRequiredDescriptionDefault
qYesMolecule name or term, letters, digits, spaces and hyphens, 2 to 100 characters
maxNoHow many molecules, 1 to 20 (default 5)

Output Schema

NameRequiredDescriptionDefault
queryNo
totalNo
sourceNo
checkedAtNo
moleculesNo

Schema Changelog

Changes observed during successful MCP inspections.

  1. First observed

TDQS

A3.5/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint and openWorldHint. The description adds useful behavioral context beyond that: result cap of 20 per call, total match count, per-call pricing, payment methods, and that failed calls are not charged.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The definition is appropriately brief and front-loads the search purpose, followed by limits and pricing. The list of returned fields is somewhat dense but still serves to orient the caller.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With complete parameter schema coverage, an output schema, and safety annotations, the description provides enough context to invoke the tool correctly. The main missing piece is sibling differentiation, which is scored separately under usage guidelines.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, so both q and max are fully documented in the input schema. The description does not add further semantics about the query syntax or how matching works, so the baseline 3 is appropriate.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose4/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a specific verb and resource: "EMBL-EBI ChEMBL molecule search," and lists the main result fields. It is clear what the tool does, but it does not distinguish itself from sibling chemical tools such as health_pubchem_chemical_cid or health_drugbank_interaction.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines2/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It provides no explicit guidance on when to use this tool versus alternatives, such as PubChem, DrugBank, RxNorm, or other ChEMBL-related searches. Usage is only implied by the name and description.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

Resources